Skip to content
10-Q

Quarterly Report

Co-Diagnostics, Inc. CODX

0001493152-26-023085

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 12, 2026 3.6M sh
Shares Diluted Q1 2026 · Mar 31, 2026 2.25M sh
Shares Diluted restated Q1 2026 · Mar 31, 2025 1.07M sh
Capex Q1 2026 · Mar 31, 2026 $142.02K
Capex Q1 2026 · Mar 31, 2025 $91.91K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$7.85M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$8.75M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $8.23M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $11.88M
Stockholders Equity Q1 2026 · Mar 31, 2026 $16.04M
Stockholders Equity Q1 2026 · Dec 31, 2025 $20.63M
Stockholders Equity restated Q1 2026 · Mar 31, 2025 $47.48M
Stockholders Equity restated Q1 2026 · Dec 31, 2024 $53.88M
Current Liabilities Q1 2026 · Mar 31, 2026 $4.28M
Current Liabilities Q1 2026 · Dec 31, 2025 $3.54M
Total Liabilities Q1 2026 · Mar 31, 2026 $5.46M
Total Liabilities Q1 2026 · Dec 31, 2025 $4.11M
Current Assets Q1 2026 · Mar 31, 2026 $9.78M
Current Assets Q1 2026 · Dec 31, 2025 $13.69M
Total Assets Q1 2026 · Mar 31, 2026 $21.5M
Total Assets Q1 2026 · Dec 31, 2025 $24.74M
Eps Diluted Q1 2026 · Mar 31, 2026 −$4.06
Eps Diluted restated Q1 2026 · Mar 31, 2025 −$7.05
Eps Basic Q1 2026 · Mar 31, 2026 −$4.06
Eps Basic restated Q1 2026 · Mar 31, 2025 −$7.05
Sga Expense Q1 2026 · Mar 31, 2026 $2.5M
Sga Expense Q1 2026 · Mar 31, 2025 $2.77M
Rd Expense Q1 2026 · Mar 31, 2026 $5.93M
Rd Expense Q1 2026 · Mar 31, 2025 $4.87M
Net Income Q1 2026 · Mar 31, 2026 −$9.14M
Net Income Q1 2026 · Mar 31, 2025 −$7.53M
Operating Income Q1 2026 · Mar 31, 2026 −$9.21M
Operating Income Q1 2026 · Mar 31, 2025 −$8.55M
Gross Profit Q1 2026 · Mar 31, 2026 −$47.81K
Gross Profit Q1 2026 · Mar 31, 2025 $28.69K
Cost Of Revenue Q1 2026 · Mar 31, 2026 $193.77K
Cost Of Revenue Q1 2026 · Mar 31, 2025 $21.59K
Revenue Q1 2026 · Mar 31, 2026 $145.95K
Revenue Q1 2026 · Mar 31, 2025 $50.28K